Wordt geladen...
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval
The Food and Drug Administration (FDA) and European Medicines Agency (EMA) now have expedited review procedures for new drugs. We compared the review times of medicines licensed by the 2 agencies and explored differences in the evidence submitted. In 2015–2017 the FDA licensed 113 drugs, 66 of which...
Bewaard in:
| Gepubliceerd in: | Br J Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6983504/ https://ncbi.nlm.nih.gov/pubmed/31657044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14130 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|